Podiatrists in Lovington, NM Accepting Medicare

2 Podiatrists found. Showing 1 - 2

Jordan Parley Day, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1600 N Main Ave, Lovington, NM 88260 Phone: 575-396-6611

Jla Senior Footcare Nm Llc Podiatrist - Foot Surgery Medicare: Not Enrolled in Medicare Practice Location: 1600 W Ave I, Lovington, NM 88260 Phone: 575-396-5212

News Archive

Combination of adult stem cells and parathyroid hormone may speed healing process for bone fractures

A combination of adult stem cells and parathyroid hormone significantly increased new bone formation in laboratory animals and may speed the healing process for human bone fractures caused by osteoporosis, a new study shows.

ACC Middle East Conference 2019 brings together leading experts to discuss global burden of NCDs

The American College of Cardiology is again partnering with the Emirates Cardiac Society to host the ACC Middle East Conference 2019 together with the 10th Emirates Cardiac Society Congress on Oct. 3-5, 2019, in Dubai, United Arab Emirates.

Research finding points towards developing effective malaria vaccine

In a recent breakthrough to combat malaria, a collaboration of Indian and American scientists have identified a malarial parasite protein that can be used to develop antibodies when displayed on novel nanoparticles. This approach has the potential to prevent the parasite from multiplying in the human host and also inhibits transmission through mosquitoes. The finding points towards developing a powerful malaria vaccine in the hope of eradicating this debilitating and often fatal disease.

Unisense FertiliTech's EmbryoViewer software gets FDA approval for IVF practices

World leading time-lapse technology provider within the field of IVF, Unisense FertiliTech A/S, has received FDA 510(k) clearance for its "Compare & Select" feature in the EmbryoViewer software - an accessory to the EmbryoScope time-lapse incubator - which assists IVF professionals in selecting embryos for transfer when treating infertile couples or individuals wishing to become a parent.

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.

Read more Medical News

› Verified 3 days ago